Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/12669
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wimmer, Verena C | en |
dc.contributor.author | Li, Melody Y-S | en |
dc.contributor.author | Berkovic, Samuel F | en |
dc.contributor.author | Petrou, Steven | en |
dc.date.accessioned | 2015-05-16T02:23:48Z | |
dc.date.available | 2015-05-16T02:23:48Z | |
dc.date.issued | 2015-03-04 | en |
dc.identifier.citation | Neurology 2015; 84(13): 1308-16 | en |
dc.identifier.govdoc | 25740860 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/12669 | en |
dc.description.abstract | The human GABAAγ2(R43Q) mutation is associated with genetic epilepsy. Because of the role of γ-aminobutyric acid (GABA) in brain development, we asked whether this epilepsy mutation might affect excitability by changing cortical cytoarchitecture.We used a mouse model harboring a heterozygous R43Q missense mutation in the GABAA receptor subunit γ2, as identified in a family with absence epilepsy and febrile seizures. Three-dimensional quantification of immunostained neurons (NeuN), inhibitory neurons (GABA), and inhibitory neuron subpopulations (calretinin, parvalbumin, and calbindin) was performed in fiducial somatosensory cortical columns of seizure-naive GABAAγ2(R43Q) and control mice.Of note, the densities of GABA-, calretinin-, parvalbumin-, and calbindin-containing neurons were increased, and somewhat perplexing, the ratio between putative excitatory and inhibitory neurons was decreased in GABAAγ2(R43Q) mice. Differences were detected in a layer-specific manner with greater overall effects in layers 2/3, 5, and 6, as compared with layers 1 and 4.Our results suggest that the γ2(R43Q) mutation significantly affects cortical microcircuitry in the cortex of this model of human genetic epilepsy. | en |
dc.language.iso | en | en |
dc.title | Cortical microarchitecture changes in genetic epilepsy. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Neurology | en |
dc.identifier.affiliation | From The Florey Institute of Neuroscience and Mental Health (V.C.W., M.Y.-S.L., S.P.) and Centre for Neuroscience (S.P.), University of Melbourne; and Epilepsy Research Centre and Department of Medicine (S.F.B.), University of Melbourne, Austin Health, Australia | en |
dc.identifier.doi | 10.1212/WNL.0000000000001415 | en |
dc.description.pages | 1308-16 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/25740860 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Berkovic, Samuel F | |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Epilepsy Research Centre | - |
crisitem.author.dept | Neurology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.